SCHMC

A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial

Metadata Downloads
All Author(s)
Joohyuk Sohn ; Gun Min Kim ; Kyung Hae Jung ; Hei-Cheul Jeung ; Jieun Lee ; Keun Seok Lee ; Seock-Ah Im ; Seok Yun Kang ; Se Hyun Kim ; Han Jo Kim ; Kyong Hwa Park ; Yee Soo Chae ; Su-Jin Koh ; EUN KYUNG CHO ; Keon Uk Park ; Sung Sook Lee ; Ji-Yeon Kim ; In Sil Choi ; Sun Kyung Baek ; Yong Wha Moon
Intsitutional Author(s)
김한조
Issued Date
2024
Type
Conference
Conference Name
2024 ASCO Annual Meeting
Citation Title
JOURNAL OF CLINICAL ONCOLOGY
Citation Start Page
LBA502
Citation End Page
LBA502
Language(ISO)
eng
DOI
10.1200/JCO.2024.42.17_suppl.LBA502
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/4722
Appears in Collections:
종양혈액내과 > 2. Conference Papers
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.